Please login to the form below

Not currently logged in
Email:
Password:

Quanticate names chief operating officer

Alan Morgan joins the data-focused clinical research organisation

Quanticate Alan MorganLondon-based clinical research organisation Quanticate has appointed Alan Morgan as its chief operating officer.

Morgan will oversee the data-focused firm's global office network across India, Poland, South Africa, the UK and the US with a view to expanding its client base in clinical data services.

He joins from both Oxfordshire Life Sciences, a consulting and advisory service, where he served as managing director, and pharma services provider Concept Life sciences, which he co-founded in 2014 and served as its chief executive.

Previously, Morgan served as ICON's group president for clinical research services, and has held a number of finance management roles at AstraZeneca, Covance, GlaxoSmithKline, MDS and RPS.

David Underwood, chief executive of Quanticate, said: “Alan will be a real asset to both Quanticate and our customers as he will help to continue to optimize our processes while providing strategic direction for the future.

“As the clinical data experts, Alan's leadership over our operational teams will ensure the highest quality is delivered at all times to our customers and our leading position in the marketplace as a niche data-focused CRO is continually strengthened.”

7th October 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics